Objective: The feasibility and efficacy of the pneumatic 'Berlin Heart' ventricular assist device (VAD) were evaluated in 14 pediatric patients with profound cardiogenic shock refractory to conventional therapy. Methods: There were two patient groups. Eleven patients, aged 2 weeks-15 years and weighing 3.2 -52 kg received a left ventricular assist device or a biventricular assist device as a bridge to cardiac transplantation (bridge group). Nine of them had liver, kidney, or lung dysfunction before device implantation. Three patients were supported with a biventricular assist device for myocardial recovery (recovery group): a 6-month-old girl for postcardiotomy shock, a 10-month-old girl for allograft failure after cardiac transplantation, and a 4-year-old boy with acute myocarditis. Results: In the bridge group, eight patients were transplanted after a bridge duration of 6 -98 days (mean, 32 days) with five long-term survivors. Organ functions were normalized during bridging in all of the transplant recipients. In the recovery group, the first patient was removed from support after 2 days because of irreversible brain damage. The second patient was weaned from biventricular support after 8 days, but suffered from recurrent allograft failure. The third patient received biventricular support for 21 days followed by extracorporeal membrane oxygenation and was subsequently discharged from the hospital. Conclusions: The 'Berlin Heart' VAD can keep selected infants and children with life-threatening heart failure for weeks or months. © 1997 Elsevier Science B.V.
Introduction
The use of mechanical circulatory support in the pediatric population has been limited due to the scarcity of suitable devices. Although the use of miniaturized intra-aortic balloon pumps in children has been occasionally reported [16, 22] , its use in this cohort has been hampered by difficulties with insertion into small vessels and synchronization to a rapid heart rate. Its efficacy has further been questioned in small children because of increased aortic compliance.
Over the last decade, circulatory support in pediatric cardiac surgery has been most commonly provided through extracorporeal membrane oxygenation (ECMO) [8, 11, 17, 24] . The capability of ECMO to provide biventricular cardiac as well as respiratory support may be beneficial in maintaining circulation in children, especially those with congenital heart defects. Recently, some reports have described successful use of a centrifugal ventricular assist device (VAD) in children for cardiogenic shock after congenital heart surgery [4, 9] , donor heart failure, and bridge to cardiac transplantation [18] . However, the impossibility of mobilizing the patient, pulseless flow, and short durability of the components are disadvantages for long-term support with ECMO or centrifugal VADs. Fig. 1 . The Berlin Heart adult-sized VAD (stroke volume: 50 ml) with special silicon inlet and outlet cannulas (above), and the pediatric VAD (stroke volume: 15 ml) with a right-angle venous cannula and straight-tip aortic cannula (below).
This report describes experience at the German Heart Institute, Berlin, with the use of the Berlin Heart VAD since 1990 as a bridge to cardiac transplantation or for recovery of myocardial function in 14 infants and children.
Materials and methods

Description of de6ices
The Berlin Heart VAD (Berlin Heart GmbH, Berlin, Germany) is a paracorporeally placed, air-driven blood pump consisting of a polyurethane housing with an integrated diaphragm which forms a continuous blood contact interior (Fig. 1) . Because of the multilaminar construction of the diaphragm, the single membrane can be very thin, thus providing high flexibility, even at the diaphragm-housing junction [7] . The adult-sized VAD has c21 Bjork-Shiley tilting disc valves and stroke volumes of 50 or 60 ml. Several different types of special silicon inlet cannulas for the atria and outlet cannulas for the aorta or pulmonary artery are available. The atrial cannulas have various tip lengths (22, 26 , 30 mm) with a small screen to prevent occlusion by the atrial wall. Arterial cannulas are bent at angles of 45°, 60°, or 85°with a Dacron ring at the end for the end-to-side anastomosis with the vessel. The pediatric VAD incorporates polyurethane tri-leaflet valves with a diameter of 12 mm and has stroke volumes of 12, 15, 25, or 30 ml. Custom-made aortic and venous cannulas for cardiopulmonary bypass can be used for implantation.
The electropneumatic console/drive unit (Heimes HD-7, Vetschauer, Germany) is capable of operating two blood pumps in an alternate left-right fixed rate mode. Two computer disk drives, for a program and data diskette, respectively, together with a built-in computer and keyboard, allow for easy analysis and supervision of the system. All important values such as drive pressure, left and right pump flow, left and right stroke volume, and calculated hemodynamic parameters are displayed on the screen. This semi-portable unit, weighing less than 10 kg, has a completely redundant backup system and an internal energy source enabling independent operation for more than 6 h.
Implantation and management
For the implantation of an adult-sized left ventricular assist device (LVAD), a purse-string suture was placed immediately posterior to the interatrial groove near the origin of the right upper pulmonary vein and the inflow cannula inserted through this into the left atrium and secured by mattress sutures. The outflow cannula was anastomosed to the ascending aorta with mattress sutures [23] . In the case requiring biventricular assist device (BVAD), an additional VAD was installed between the right atrium and the main pulmonary artery in a similar fashion. In order to implant a pediatric VAD, a right-angle atrial cannula (Polystan, Varlose, Denmark) and a straight tip aortic cannula (Jostra Medizintechnik GmbH, Hirrlingen, Germany) were inserted through two purse-string sutures and secured with silicon rubber tourniquets. The transcutaneous course of the cannulas was made by tunneling through the abdominal wall in the epigastrium. The sternum was subsequently closed in all patients. Anticoagulation was maintained with continuous heparin infusion to keep an activated clotting time of 160 -180 s. Pump operation was monitored daily and, if necessary, readjusted to achieve maximal diaphragm movement. Patients who could be extubated were transferred to an intermediate ward to promote rehabilitation.
Patient population
Fourteen patients under 16 years of age were supported with the Berlin Heart VAD as a bridge to cardiac transplantation or for recovery of myocardial function. Patient data and type of support are listed in Table 1 .
Bridge group
Six girls and five boys with an average age of 10.1 years (range: 2 weeks -15 years) and an average weight of 34.9 kg (range: 3.2 -52 kg) received LVAD or BVAD. All but one patient presented with cardiomyopathy (five idiopathic, five secondary). A 2-week-old baby with pulmonary atresia with an intact ventricular septum suffered from massive myocardial infarction 10 days after a modified Blalock-Taussig shunt and received 15-ml LVAD. Patients 3, 5 and 8 required emergency VAD implantation under CPR. Patient 8, weighing 14 kg, received an adult-sized BVAD due to the unavailability of pediatric VAD.
Reco6ery group
Three patients were supported with pediatric VADs. Patient 1 suffered sudden cardiac arrest 32 h after closure of ventricular septal defect. Biventricular support was initiated under CPR. Patient 2, who had undergone left internal thoracic artery to left anterior descending artery bypass for ostium atresia of the left coronary artery at the age of 8 months, underwent heart transplantation. She developed severe allograft failure and could only be weaned from cardiopulmonary bypass with BVAD after 7 h of reperfusion. Patient 3, who presented with acute myocarditis, developed progressive dyspnea and hypotension. He suffered cardiac arrest in the intensive care unit and BVAD was implanted under CPR.
Results
VAD stroke volume index, VAD flow index, duration of support, complications, and clinical outcome are summarized in Table 2 .
Bridge group
Eight of the 11 patients subsequently underwent heart transplantation after a mean bridge duration of 32 days (range: 6-98 days); five were later discharged from the hospital. Thus, post-transplantation survival was 62.5% and survival from device implantation to patient discharge was 45.5%. VAD flow indexes ranged Table 2 Results of VAD support as a bridge to heart transplantation and for myocardial recovery in infants and children . Three patients died while receiving ventricular support due to systemic (right) ventricular perforation in patient 3, respiratory failure in patient 4, and severe hypoxemia in patient 5. Three patients did not survive heart transplantation. Patient 1 suffered from right ventricular failure of donor heart and thus required right ventricular assist device. Double bridge procedure was successful 2 days later, but she again developed donor heart failure during the second transplantation. Patient 9 could not be weaned from cardiopulmonary bypass after transplantation due to suprasystemic pulmonary hypertension, was placed on ECMO, yet subsequently died due to uncontrollable bleeding. Patient 11 had severe adhesion in the mediastinum after 72 days of support, which made establishing cardiopulmonary bypass difficult. After aortic cannula was placed, a massive amount of air was recognized in the cannula and the aorta immediately clamped. An atrial septal defect with a diameter of 15 mm was found in the explanted heart. Although transplantation was performed without incident, brain death was diagnosed 2 days later.
Significant complications were encountered in seven of the 11 patients. Bleeding was the most common problem necessitating reexploration in six patients. With the exception of patient 3, however, bleeding was not directly related to the outcome in any patient. Despite meticulous anticoagulation monitoring, thrombus formation in the blood chamber or on the mechanical valves necessitated exchanging the pumps in three patients; twice in patient 6, five times in patient 7, and three times in patient 8. Computed tomography confirmed cerebral infarction in two of these patients. Cause of thrombus in patient 8 was obviously mismatch of VAD stroke volume to her body size. In the other, however, there was no relation between the incidence of thrombus formation and VAD stroke volume index or duration of support. Although seven patients had leukocytosis (\ 12,000/mm 3 ) before device implantation, neither local nor systemic infection was noted in any of the 11 patients.
The recovery of major organ function was evaluated by comparing pre-implant data with those measured immediately before device explantation, i.e. upon trans-plantation or death. Six patients had liver dysfunction (glutamic-pyruvic transaminase \100 IU/l) before support (Fig. 2) . However, this improved in all but one of them and they subsequently underwent transplantation. Pre-implant renal dysfunction (serum creatinine\ 1.5 mg/dl) was observed in three patients (Fig. 3) . One who developed renal failure requiring hemodialysis died before transplantation, but the other two underwent transplantation after recovery of renal function. Four patients had respiratory failure requiring mechanical ventilation before VAD implantation (Fig. 4) . Only one could be extubated and subsequently undergo transplantation; another died on VAD within 1 week of its initiation. Seven patients without pre-implant respiratory failure were all transplanted. Two of them underwent transplantation without extubation, but both were long-term survivors.
As of August 1995, the average follow-up time of the five survivors was 35 months (range: 25 -58 months). Patient 2 underwent repair of coarctation of the aorta 18 months after heart transplantation. Neurological deficits which developed in two patients who had suffered cerebral infarction during bridging resolved, and thus all five children enjoy an active daily life. 
Reco6ery group
Patient 1 had anuria before BVAD implantation, but a 12-ml VAD generated excellent pulsatile blood pressure (Fig. 5 ) and renal function recovered soon after initiation of support. Despite normal hemodynamics, Fig. 2 . Recovery of hepatic function during bridge to transplantation. brain death, which may have developed during an episode of cardiac arrest, was diagnosed and biventricular support subsequently discontinued on the second day.
Patient 2 initially received biventricular support at a maximum pump rate of 110 beats/min after transplantation. On the following day, transesophageal echocardiography indicated an improvement in cardiac allograft function, though reexploration was necessary once due to bleeding. On the third day, the BVAD flow was reduced to 75% and further to 50% the next day. On the eighth day, the patient was weaned from the BVAD. However, 10 h later, left ventricular function had deteriorated and the chest was reopened. Despite receiving maximal inotropic support, the patient died from recurrent donor heart failure 2 days after weaning from BVAD.
Patient 3 had stable hemodynamics with no improvement in myocardial function during the first 2 weeks of biventricular support. Thereafter, serial echocardiographic evaluation indicated a gradual recovery in cardiac function. Because of difficulty with weaning, BVAD was converted to ECMO for biventricular support on the 21st day. Although the patient required reexploration once due to bleeding, he ultimately could be weaned from ECMO after 5 days. Upon discharge, echocardiography showed good biventricular function with a left ventricular ejection fraction of 64%.
Discussion
Results from the 14 patients in this study indicate that the Berlin Heart VAD can maintain the circulation in infants and children threatened by imminent heart failure. However, the unfavorable outcome of the 2-weekold baby with interatrial communication suggests that the type of mechanical circulatory support in pediatric patients must be carefully selected according to the underlying cardiac anatomy. Although circulatory support with a VAD is possible in the univentricular heart with shunt-dependent pulmonary circulation [9] , Matsuda et al. reported difficulties with VAD support in this setting [13] . We believe that common atrium/univentricular heart circulation is an indication for ECMO.
Left ventricular support with a centrifugal pump has proven effective for cardiogenic shock after pediatric cardiac surgery and was feasible even in a 1.9-kg baby [10] . On the other hand, due to the lack of suitable devices, ECMO has still been the first choice for biventricular support in small children, regardless of the existence or not of respiratory failure. The results of ECMO for cardiac support attained a survival rate of 45% [20] , but a pneumatic BVAD, if available, is clearly ideal for biventricular support in selected patients. Taenaka et al. first developed a miniaturized pneumatic VAD with a stroke volume of 20 ml which was applied as a LVAD for postcardiotomy shock in two children with univentricular hearts [13] and two with biventricular hearts [21] . As observed in the recovery group in this study, pneumatic 12-ml BVAD can be implanted with excellent function in the smallest patient (7 kg). Since the smaller Berlin Heart VADs with stroke volumes of 8 and 10 ml have been recently developed, biventricular support using pneumatic VADs may now be possible without lower limitations in patients body size.
Options for mechanical circulatory support in pediatric patients awaiting heart transplantation are more limited. Recently, some reports [1, 2, 6] have described the extended use of ECMO as a bridge to pediatric heart transplantation, usually with durations of less than 2 weeks. Considering the particular shortage of pediatric donor hearts and the tendency of increasing bridging time in adults (mean: 35 days in 75 transplanted patients at our institution [19] ), using ECMO for bridging in children may be hazardous. Undoubtedly, pneumatic VADs are preferable to ECMO for long-term circulatory support. The problem of limited pericardial space is the major surgical concern for VAD implantation in children, especially in cases requiring BVAD which needs four cannulas. However, older children awaiting transplantation often suffer heart failure with resulting dilatation of the cardiac chambers and thus adult-sized VAD equipment, as was the case for most of the patients in the bridge group, is applicable. The results of the recovery group also suggest the possibility of chronic biventricular support in infants and small children.
Increasing experience with mechanical circulatory support as a bridge to heart transplantation in adults has shown that the recovery from endstage organ failure [3, 5] and an improvement in patient mobilization [12, 14] during bridging are important factors for the ultimate success of transplantation. In this series, more than half of the patients had major organ dysfunctions before device implantation. All eight patients underwent heart transplantation after recovering hepatic and renal functions, but respiratory failure requiring mechanical ventilation seems to have a negative impact on the outcome of pediatric heart transplantation following VAD support.
Five of the bridge group patients (46%) and one of the recovery group patients (33%) were reoperated on due to VAD-related bleeding. According to reports of Pennington et al., in adult patients who were supported with the Pierce-Donachy VAD, incidence of bleeding has been decreasing with experience; from 64 to 26% in bridge patients and from 73 to 48% in recovery patients [14, 15] . Therefore, surgical skill in VAD implantation will reduce this iatrogenic complication. Cerebral infarction related to thrombus in the VAD was a complication of two patients. If VAD stroke volume is too big for patient's body size, a reduction in pump rate is necessary in order to achieve adequate pump filling. Thus, poor wash-out of the blood contacting surface of the pump can lead to thrombus formation. Although it is apparent that selecting the appropriate pump is important for successful VAD support, so far, we have not established a specific pump stroke volume suitable for body size in pediatric patients.
In conclusion, circulatory support with the Berlin Heart pneumatic VAD has proven to be feasible and effective in providing a bridge to heart transplantation or promoting recovery of failing myocardium in selected infants and children. The best candidates for its application may be patients with biventricular hearts without intracardiac shunts. Better patient selection and earlier indication may improve survival after VAD support.
